Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States

• Published in: PloS one Vol. 11; no. 11; p. e0166828
• Main Authors: Yang, Baiyu, Shebl, Fatma M, Sternberg, Lawrence R, Warner, Andrew C, Kleiner, David E, Edelman, Daniel C, Gomez, Allison, Dagnall, Casey L, Hicks, Belynda D, Altekruse, Sean F, Hernandez, Brenda Y, Lynch, Charles F, Meltzer, Paul S, McGlynn, Katherine A
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 23.11.2016; Public Library of Science (PLoS)
• Subjects: Aged; Analysis; Biology and Life Sciences; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - pathology; Chromosomes; Demography; Earth Sciences; Female; Hazards; Hepatocellular carcinoma; Humans; Liver cancer; Liver Neoplasms - genetics; Liver Neoplasms - mortality; Liver Neoplasms - pathology; Male; Measurement methods; Medical diagnosis; Medical prognosis; Medicine and Health Sciences; Middle Aged; Mortality; Multiplex Polymerase Chain Reaction; Neoplasm Grading; Neoplasm Staging; Pathology; Patient outcomes; Patients; People and Places; Polymerase chain reaction; Prognosis; Proportional Hazards Models; Survival; Telomere - metabolism; Telomere Shortening; Telomeres; Tissues; Tumors; United States; Hawaii; Iowa; United States > US; Connecticut
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0166828

Telomere shortening is an important molecular event in hepatocellular carcinoma (HCC) initiation; however, its role in HCC progression and prognosis is less clear. Our study aimed to examine the association of telomere length with survival of patients with HCC. We measured telomere length in tumor and adjacent non-tumor tissues from 126 persons with HCC in the United States (U.S.) who were followed for mortality outcomes. Relative telomere length (RTL) was measured by a monochrome multiplex quantitative polymerase chain reaction assay. Multivariable Cox proportional hazards modeling was used to calculate hazard ratios (HRs) and 95% CIs for the association between telomere length and all-cause mortality. We also examined associations between telomere length and patient characteristics using multiple linear regression. During a mean follow-up of 6.0 years, 79 deaths occurred among 114 individuals for whom survival data were available. The ratio of RTL in tumor relative to non-tumor tissue was greater for individuals with regional or distant stage tumors (0.97) than localized stage tumors (0.77), and for individuals with grade III or IV tumors (0.95) than grade II (0.88) or grade I (0.67) tumors. An RTL ratio ≥1 was not associated with survival (HR 0.92, 95% CI 0.55, 1.55) compared to a ratio <1, after adjusting for age at diagnosis, sex, tumor stage and tumor size. Similarly, RTL in the tumor and non-tumor tissue, respectively, were not associated with survival. This U.S. based study found that telomeres may be longer in more aggressive HCCs. There was no evidence, however, that telomere length was associated with survival of patients with HCC. Future investigations are warranted to clarify the role of telomere length in HCC prognosis.